Saturday, July 09, 2011 12:23:59 PM
being a doc, i can tell u few things:
1. I dont think FDA or company would be in the process of expanding the lable, FDA probably would know that it will be used OFF lable. it happens all the time. company can not promote for it , but doctors usually, determine with their best judgement , if this drug/ technology is safe or not for the patient and effective or not, and they use it off lable. with La viv, i am very sure that most of the dermatologist and plastic surgeon will use it off lable , if the product is successful, which i think it will!
2. company has said before that they are in discussion with FDA for validity of acne scar study. That will be one news in the near term i am expecting, and company should be doing this discussion and not the lable discussion, just my opinion.
I sold and bought back after atown said that , company responded to his voicemail finally. At lease i wanted to hear from the company that they are in quite period. slowly good news will start to flow and stock should be significantly higher than it is today.
above are just my opinion.
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM